Ulcerative Colitis Clinical Case Review

Michael Dolinger, MD, an assistant professor of pediatric gastroenterology at the Icahn School of Medicine and Mount Sinai Kravis Children's Hospital, discusses the results of the case:

Editor’s note: The following is an automatically generated transcript of the above video.

“She starts ozanimod [Zaposia; Bristol Myers Squibb] treatment, and within eight weeks, she goes into clinical remission. She returns to school for the fall semester, begins her sophomore year, and we also transition her to a local adult gastroenterologist for the first time while at school in case she flares again to give her that reassurance. And she's able to really begin the sophomore year without worrying about her ulcerative colitis.

When she comes back on fall break, we repeat an ultrasound, and this is what it looks like. Now, again, you may have not seen these ultrasound video loops, so it may not be so familiar to you, but it's very hard to see normal thin bowel wall here. You can see this is the psoas muscle and here's the sigmoid colon above. This is what it looks like. The wall layers are barely visible because all her inflammation is completely gone, and she has healing again. We didn't need a scope. We didn't need stool tests. We didn't need blood tests to see that her colon is now healed, and this is her left colon, and her entire colon was completely healed.”